Alex Barker, PhD, of Chicago-based Northwestern University Feinberg School of Medicine, and Paul Fedak, MD, PhD, of Canada-based University of Calgary Cumming School of Medicine, will co-lead the five-year clinical research study. The research team will use a new real-time, 3-D blood flow visualization and tissue analysis technique to inform personalized treatments for bicuspid aortic valve patients.
“Not all BAV patients are the same, yet they are currently treated the same when it comes to timing and extent of surgery,” said Dr. Fedak. “Through this study we can give clinicians and surgeons the tools they need to create precise, individualized treatment plans for patients.”
More articles on health IT:
CloudHealth Technologies gains $46M in new funding round
Kyruus names general counsel, chief administrative officer
West Virginia hospital to replace 1.2k hard drives after ransomware attack
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
